Mycophenolate After Stem Cell Transplant for Systemic Sclerosis | MicrobiomeTrials← Back to trialsNCT07734012
Mycophenolate After Stem Cell Transplant for Systemic Sclerosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-08Est. Completion: 2028-12
Enrollment target: 6 participants Locations- The Ottawa Hospital, Ottawa, Ontario, Canada
Other microbiome trials you might be interested in
Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Sjogren's Disease
This is a phase I, open-label study of ATG-201 in participants with autoimmune diseases.
Bengbu, ChinaEst. completion Dec 1, 2028
Systemic SclerosisIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell th…
Tucson, United StatesEst. completion Feb 22, 2028